Market News

Alnylam Pharmaceuticals (ALNY) Shares Rose While Axa Has Lowered by $11.80 Million Its Stake; Seizert Capital Partners Increases Holding in C H Robinson Worldwide Com (CHRW)

Seizert Capital Partners Llc increased its stake in C H Robinson Worldwide Inc Com (CHRW) by 0.94% based on its latest 2017Q3 regulatory filing with the SEC. Seizert Capital Partners Llc bought 7,368 shares as the company’s stock declined 14.80% while stock markets rallied. The institutional investor held 787,815 shares of the transportation company at the end of 2017Q3, valued at $59.95 million, up from 780,447 at the end of the previous reported quarter. Seizert Capital Partners Llc who had been investing in C H Robinson Worldwide Inc Com for a number of months, seems to be bullish on the $12.77B market cap company. The stock decreased 1.30% or $1.2 during the last trading session, reaching $91.42. About 304,263 shares traded. C.H. Robinson Worldwide, Inc. (NASDAQ:CHRW) has declined 7.85% since February 20, 2017 and is downtrending. It has underperformed by 24.55% the S&P500.

Axa decreased its stake in Alnylam Pharmaceuticals Inc (ALNY) by 71.45% based on its latest 2017Q3 regulatory filing with the SEC. Axa sold 100,894 shares as the company’s stock rose 48.45% with the market. The institutional investor held 40,316 shares of the health care company at the end of 2017Q3, valued at $4.74M, down from 141,210 at the end of the previous reported quarter. Axa who had been investing in Alnylam Pharmaceuticals Inc for a number of months, seems to be less bullish one the $12.21B market cap company. The stock decreased 0.31% or $0.385 during the last trading session, reaching $122.495. About 101,915 shares traded. Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) has risen 33.54% since February 20, 2017 and is uptrending. It has outperformed by 16.84% the S&P500.

Since September 20, 2017, it had 0 buys, and 3 insider sales for $23.18 million activity. $10.66M worth of stock was sold by Greene Barry E on Monday, October 2.

Investors sentiment decreased to 0.92 in 2017 Q3. Its down 0.60, from 1.52 in 2017Q2. It fall, as 30 investors sold ALNY shares while 73 reduced holdings. 40 funds opened positions while 55 raised stakes. 86.02 million shares or 0.72% more from 85.40 million shares in 2017Q2 were reported. Morgan Stanley stated it has 0.03% of its portfolio in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY). Fmr Limited Liability Com holds 0.2% or 13.76M shares. 59,860 were reported by Dekabank Deutsche Girozentrale. Pnc Service Grp reported 0% of its portfolio in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY). Victory stated it has 0.01% of its portfolio in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY). Sei Communications holds 0.02% or 50,156 shares in its portfolio. New York-based Metropolitan Life Insurance has invested 0% in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY). 1.53M are held by Blue Ridge Limited Company. Segall Bryant Hamill Ltd Llc holds 2,000 shares or 0.01% of its portfolio. Bancshares Of America De owns 74,897 shares. Pub Employees Retirement Sys Of Ohio holds 0.02% of its portfolio in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) for 32,880 shares. 221,628 are owned by Pictet Asset Mngmt. Aperio Grp Ltd Liability Com stated it has 16,908 shares or 0.01% of all its holdings. Michigan-based World Asset Mgmt has invested 0.01% in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY). Moreover, Knott David M has 0.01% invested in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY).

Axa, which manages about $23.21 billion US Long portfolio, upped its stake in Q2 Hldgs Inc (NYSE:QTWO) by 10,000 shares to 91,000 shares, valued at $3.79 million in 2017Q3, according to the filing. It also increased its holding in Hyster Yale Matls Handling I (NYSE:HY) by 27,666 shares in the quarter, for a total of 54,830 shares, and has risen its stake in Canadian Nat Res Ltd (NYSE:CNQ).

Among 23 analysts covering Alnylam Pharmaceuticals (NASDAQ:ALNY), 17 have Buy rating, 1 Sell and 5 Hold. Therefore 74% are positive. Alnylam Pharmaceuticals had 97 analyst reports since August 7, 2015 according to SRatingsIntel. The company was maintained on Thursday, September 7 by Piper Jaffray. The firm has “Equal-Weight” rating by Morgan Stanley given on Thursday, September 21. The firm earned “Buy” rating on Sunday, January 7 by Piper Jaffray. The rating was initiated by Ladenburg Thalmann on Thursday, February 2 with “Buy”. Piper Jaffray maintained it with “Buy” rating and $182.0 target in Friday, December 15 report. The rating was maintained by BMO Capital Markets with “Buy” on Thursday, February 8. The rating was reinitiated by Barclays Capital with “Overweight” on Thursday, September 7. Needham maintained Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) on Thursday, September 21 with “Buy” rating. Jefferies maintained it with “Buy” rating and $58 target in Thursday, October 6 report. Morgan Stanley initiated Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) on Tuesday, August 2 with “Overweight” rating.

Among 23 analysts covering C.H. Robinson Worldwide (NASDAQ:CHRW), 9 have Buy rating, 2 Sell and 12 Hold. Therefore 39% are positive. C.H. Robinson Worldwide had 86 analyst reports since July 30, 2015 according to SRatingsIntel. The rating was maintained by Stifel Nicolaus on Wednesday, October 26 with “Buy”. Cowen & Co maintained the stock with “Hold” rating in Friday, September 29 report. The firm has “Market Perform” rating given on Monday, March 7 by BMO Capital Markets. Cowen & Co maintained C.H. Robinson Worldwide, Inc. (NASDAQ:CHRW) on Thursday, November 2 with “Buy” rating. The company was maintained on Thursday, July 20 by BMO Capital Markets. The company was upgraded on Thursday, January 4 by Citigroup. The company was upgraded on Thursday, February 4 by Raymond James. Cowen & Co maintained C.H. Robinson Worldwide, Inc. (NASDAQ:CHRW) rating on Monday, July 10. Cowen & Co has “Hold” rating and $7300 target. As per Thursday, August 24, the company rating was maintained by Robert W. Baird. The firm has “Underperform” rating given on Thursday, November 2 by Credit Suisse.

Seizert Capital Partners Llc, which manages about $4.45B and $2.72 billion US Long portfolio, decreased its stake in Diamondrock Hospitality Co Com (NYSE:DRH) by 32,190 shares to 268,835 shares, valued at $2.94M in 2017Q3, according to the filing. It also reduced its holding in Wal (NYSE:WMT) by 13,392 shares in the quarter, leaving it with 310,812 shares, and cut its stake in Qualcomm Inc Com (NASDAQ:QCOM).

Investors sentiment decreased to 1.01 in Q3 2017. Its down 0.23, from 1.24 in 2017Q2. It is negative, as 57 investors sold CHRW shares while 128 reduced holdings. 37 funds opened positions while 150 raised stakes. 129.16 million shares or 3.64% more from 124.62 million shares in 2017Q2 were reported. New Mexico Educational Retirement Board owns 13,129 shares or 0.05% of their US portfolio. Bancorporation Of America De has 0.01% invested in C.H. Robinson Worldwide, Inc. (NASDAQ:CHRW) for 808,393 shares. First Eagle Investment Ltd owns 6.37 million shares or 1.08% of their US portfolio. Greenleaf has invested 0% of its portfolio in C.H. Robinson Worldwide, Inc. (NASDAQ:CHRW). Zacks Investment Mgmt has 0.11% invested in C.H. Robinson Worldwide, Inc. (NASDAQ:CHRW) for 61,539 shares. Strategic Financial Serv holds 29,476 shares or 0.37% of its portfolio. Fort Washington Investment Advsrs Inc Oh invested in 18,524 shares. First Personal Svcs accumulated 16,094 shares. Fjarde Ap accumulated 0.06% or 39,128 shares. Cornerstone Cap Mgmt Holding Limited Liability reported 0.01% stake. Lowe Brockenbrough & Inc, Virginia-based fund reported 24,146 shares. The Pennsylvania-based Janney Montgomery Scott Ltd Limited Liability Company has invested 0% in C.H. Robinson Worldwide, Inc. (NASDAQ:CHRW). Moreover, Community Bancorporation Na has 0.11% invested in C.H. Robinson Worldwide, Inc. (NASDAQ:CHRW). 533,133 are owned by Tobam. Moreover, British Columbia Invest Mgmt has 0.04% invested in C.H. Robinson Worldwide, Inc. (NASDAQ:CHRW) for 70,763 shares.

Leave a Reply

Your email address will not be published. Required fields are marked *